--- title: "Antitumor Drug Development in Lviv: New Compounds and Methods" description: "Scientists at the Lviv Institute of Cell Biology are developing new antitumor drugs by researching small molecules and enzymes for cancer metabolic therapy." date: 2026-10-26T10:34:29.884Z lang: en url: https://xab.info/en/posts/lviv-scientists-develop-antitumor-drugs tags: [science, cancer-research, biotechnology, lviv, medicine, ukraine] author: "Alexander Buran" publisher: "XAB.info" --- # Antitumor Drug Development in Lviv: New Compounds and Methods ![Female scientist in a white lab coat and safety glasses working in a modern biological laboratory with test tubes and a microscope](https://xab.info/media/2026/10/26/lvovskie-uchenye-sozdayut-protivoopukholevye-preparaty/lvovskie-uchenye-sozdayut-protivoopukholevye-preparaty-1.webp) ## Key Points - The Institute of Cell Biology in Lviv is developing new antitumor compounds - Scientists use heterocyclic molecules for targeted impact on cancer cells - Metabolic therapy is based on enzymes that cleave key tumor amino acids - Developments undergo animal testing and are protected by patents Scientists at the Institute of Cell Biology of the National Academy of Sciences of Ukraine in Lviv are actively working on creating advanced antitumor drugs and discovering new biologically active compounds. This was announced by the institute's director, Kostiantyn Dmytruk, who noted that the institution's staff is distributed across several specialized departments focusing on microorganisms, cell lines, and modern biotechnology methods. ### Research Structure and Focus Areas of the Institute The Institute of Cell Biology comprises four specialized departments, each addressing unique scientific tasks. Approximately half of the institute's researchers work with microorganisms, predominantly yeast and bacteria, while the remaining specialists focus on studying healthy and cancer cell lines. The Department of Molecular Genetics and Biotechnology applies genetic engineering methods to produce valuable compounds using yeast cultures. Simultaneously, the Department of Analytical Biotechnology investigates promising enzymes to create modern biosensors and analytes. Another cutting-edge direction is the synthesis of nanozymes, which are artificial enzymes created based on nanomaterials. This multidisciplinary framework enables the institute to comprehensively address fundamental and applied tasks in modern biomedicine. ### Search for Small Molecules and Targeted Tumor Effects One of the key research areas of the institute is the search for small molecules with pronounced antitumor activity. According to Kostiantyn Dmytruk, researchers are concentrating on heterocyclic compounds that combine multiple active fragments. This approach makes it possible to obtain substances with higher efficacy and targeted impact on pathological cells. Special attention is paid to finding compounds that specifically target molecular targets in malignant cells, such as specific proteins or signaling pathways disrupted by mutations. This maximizes the therapeutic effect while minimizing the negative impact of developing drugs on healthy body tissues, the safety of which is thoroughly checked for toxicity and DNA damage. ### Metabolic Therapy and Combined Approaches Long-term research at the institute aims to create combined methods of metabolic antitumor therapy. This approach is based on using special enzymes capable of effectively cleaving amino acids critically needed by aggressive tumors, such as arginine, glutamine, and asparagine. Restricting access to these substances significantly suppresses the growth and proliferation of cancer cells. To implement this strategy, scientists have created their own microbial producers of recombinant enzymes and developed comprehensive approaches combining them with plant-derived amino acid analogues. All obtained combined compounds undergo mandatory testing on laboratory animals with tumors, and the most promising scientific results are supported by international publications and protective patents. ### Significance of Developments for Modern Medicine The creation of innovative antitumor compounds and metabolic therapy methods opens new prospects in oncology treatment. Successful trials by Lviv scientists demonstrate the high potential of Ukrainian science in developing targeted medicinal products with minimal side effects. Further implementation of these technologies into clinical practice can significantly expand the arsenal of modern oncology. ## Fact-Check & Sources - [Новые молекулы и соединения: как ученые во Львове создают противоопухолевые препараты](https://www.rbc.ua/ukr/news/novi-molekuli-y-spoluki-yak-vcheni-lvovi-1793009500.html) - The primary source confirms all information regarding the research directions of the Institute of Cell Biology in Lviv and the statements by director Kostiantyn Dmytruk. - [В РФ получили новые молекулы в качестве основы для препаратов против рака](https://tass.ru/nauka/28196725) - Подтверждено по источнику tass.ru - [Ученые ТПУ синтезировали новые молекулы в качестве основы для препаратов против рака](https://www.akm.ru/press/uchenye_tpu_sintezirovali_novye_molekuly_v_kachestve_osnovy_dlya_preparatov_protiv_raka/) - Подтверждено по источнику akm.ru - [В РФ создали новые молекулы в качестве основы для препаратов против онкологии](https://www.m24.ru/news/09102026/950430) - Подтверждено по источнику m24.ru ## FAQ ### What research directions are developed at the Lviv Institute of Cell Biology? The institute conducts work in yeast molecular genetics, analytical biotechnology, nanozyme synthesis, as well as the creation of antitumor drugs and metabolic therapy methods. ### What is the essence of the metabolic antitumor therapy approach? The method is based on using enzymes that cleave amino acids necessary for the growth of aggressive tumors (arginine, glutamine, and asparagine), thereby suppressing their development. ### How is the safety of the developed antitumor compounds checked? Potential drugs are checked for toxicity to healthy cells and the absence of damaging effects on DNA, and they also undergo testing on laboratory animals with tumors.